Rosetta Genomics Cash from Operations Quarterly
Rosetta Genomics Historical Cash from Operations Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
About Cash From Operations
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from operations. Includes the company's cash inflows and outflows from the company's core business operations.
Cash from Operations can be thought of as "how much did the firm generate in the day to day operations of the firm?"
Learn More
ROSG Cash from Operations Quarterly Benchmarks
| Companies | |
|---|---|
| Trius Therapeutics | |
| Chembio Diagnostics | -0.1907M |
| Novadaq Technologies | -0.7573M |
ROSG Cash from Operations Quarterly Range, Past 5 Years
| Minimum | -6.739M | Jun 2010 |
| Maximum | 0.00 | Sep 2008 |
| Average | -4.974M |